5 Most Profitable Biotech Stocks Today

4. Merck & Co., Inc. (NYSE:MRK)

Latest TTM Net Income Figures: $14.5 billion

Merck & Co., Inc. (NYSE:MRK) is one of the largest healthcare companies in the world. Its scale and scope enabled it to announce a big biotechnology acquisition in March, when Merck & Co., Inc. (NYSE:MRK) revealed that it will acquire a firm that develops immune system treatments for a price tag of $10.8 billion.

By the end of this year’s second quarter, 78 out of the 910 hedge funds profiled by Insider Monkey had owned the firm’s shares. Merck & Co., Inc. (NYSE:MRK)’s biggest hedge fund investor is Ken Fisher’s Fisher Asset Management since it owns 12.6 million shares that are worth $1.4 billion.

Follow Merck & Co. Inc. (NYSE:MRK)